Market Overview

Benzinga's Top Upgrades

Benzinga's Top Upgrades


  • Wedbush upgraded Workday Inc (NYSE: WDAY) from Underperform to Neutral. Workday shares rose 0.22 percent to $89.99 in pre-market trading.
  • Stifel Nicolaus upgraded Cypress Energy Partners LP (NYSE: CELP) from Hold to Buy. Cypress Energy Partners shares gained 0.34 percent to close at $8.90 on Tuesday.
  • Goldman Sachs upgraded Taubman Centers, Inc. (NYSE: TCO) from Neutral to Buy. The price target for Taubman Centers has been raised from $79 to $87. Taubman Centers shares fell 1.91 percent to close at $75.50 on Tuesday.
  • Analysts at UBS upgraded Hi-Crush Partners LP (NYSE: HCLP) from Sell to Neutral. The price target for Hi-Crush Partners has been raised from $9 to $15. Hi-Crush Partners shares fell 0.34 percent to close at $14.46 on Tuesday.
  • Analysts at Deutsche Bank upgraded Huntington Bancshares Incorporated (NASDAQ: HBAN) from Hold to Buy. Huntington Bancshares shares rose 1.13 percent to $9.85 in pre-market trading.
  • Barclays upgraded Signature Bank (NASDAQ: SBNY) from Equal-weight to Overweight. The price target for Signature Bank has been lowered from $150 to $139. Signature Bank shares rose 0.59 percent to $116.64 in pre-market trading.
  • Analysts at Credit Suisse upgraded Dillard's, Inc. (NYSE: DDS) from Neutral to Outperform. The price target for Dillard's has been raised from $63 to $70. Dillard's shares fell 0.44 percent to close at $58.21 on Tuesday.

Posted-In: top upgradesUpgrades Analyst Ratings


Related Articles (DDS + CELP)

View Comments and Join the Discussion!

Latest Ratings

TMoffett NathansonDowngrades30.0
PSABank of AmericaDowngrades
AMSWAB. Riley FBRDowngrades17.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Shopify Downgraded At Morgan Stanley After Shares Rise 70%

RBC's Bullish Neurologist Survey Leads To A $108 Price Target On Sarepta Therapeutics